Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study.

Francesca MannucciGiacomo VitturiLuca BenacchioLuca Gino SbrogiòFrancesca BanoAnnunziata LapollaFrancesco PiarulliMaria Cecilia GironAngelo Avogaro Gian Poalo Fadini

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2022)

Diabetes does not appear to modify the risk of SARS-CoV-2 infection in a clinically meaningful way, but strongly increases the rates of hospitalization and death. Insulin use was associated with worse outcomes, whereas metformin use was associated with lower mortality.

Keyphrases

type diabetes
glycemic control
coronavirus disease
sars cov
blood glucose
respiratory syndrome coronavirus
cardiovascular disease
cardiovascular events
risk factors
weight loss